Canada: So, Your Company Just Received A Cease And Desist Letter... (Part 2)

Part 1 of this article summarized the steps that should be taken if your company receives a cease and desist letter that alleges patent infringement. The first step should be to assess the type of business entity that sent the letter to determine if they are a practicing entity (PE), a non-practicing entity (NPE) or specifically a patent assertion entity (PAE). The next step should be to engage patent counsel as soon as practicably possible to assess the strength of the claim of patent infringement, and to advise on how best to respond, if at all, in view of type of entity that sent the cease and desist letter. The next step should then be a timely response letter from your patent counsel to the entity.

Part 1 also provided an overview of the different types of NPEs, including PAEs, and in the case that the cease and desist letter appears to have come from an NPE, the steps that should be taken in assessing potentially infringing activities and options for a follow up response to the NPE.

Part 2 of this article now considers responses to PAEs specifically, and implications regarding PAE-initiated litigation in Canada. 

Responses to a PAE Cease and Desist Letter

If you have determined that the cease and desist letter came from a PAE, it is even more important to engage patent counsel and have them respond in a timely manner to the PAE. A curt response from patent counsel stating that your activities do not infringe the issued claims in their patent(s) and/or that their patents are invalid will put the ball back in the PAE's court to make the next move. Some PAEs may provide proof or detailed information in an effort to demonstrate that your activities are infringing. Other PAEs may simply disappear and never follow up. Yet other PAEs may choose to pursue legal action. In the case where the PAE is considering pursuing or actually pursues legal action in Canada, a number of dynamics come into play, as discussed in more detail below.

PAE Activity in Canada

While numerous PAEs have initiated patent infringement litigation in Canada, there are aspects of the Canadian legal system that may act as a buffer against a deluge of future PAE-initiated litigation. At the same time, there are aspects of the Canadian legal system that PAEs will find attractive in their increasingly international enforcement efforts.

Cost Implications

The Canadian legal system employs a "loser pays" approach to assessing costs at the end of a trial. Canadian courts employ a sliding scale of how much of a successful party's legal fees must be covered by the unsuccessful party. This is contrary to the typical approach in the U.S. where parties often bear their own legal costs, although this may be evolving in the U.S. following cases such as Octane Fitness, LLC v. ICON Health & Fitness, Inc., 134 S. Ct. 1749 (2014). 

Although the Canadian system is a "loser pays" system, the amount recovered by a successful party is typically only about 20-30% of actual legal fees and 70-80% of actual disbursements. Combined with the reality that patent litigation as a whole is substantially cheaper in Canada than in the U.S., the total risk associated with an adverse costs award can be relatively limited. Notwithstanding the above, if the PAE's case is found by the Court to have been frivolous, or if the PAE is found to have engaged in reprehensible conduct during the litigation, a more substantial costs award could be levelled against the PAE.

As such, before a PAE asserts a Canadian patent it will have to consider the degree of risk associated with having to pay a portion of a defendant's legal fees, if the defendant is ultimately successful at trial. Because the "loser pays" regime cuts both ways in the sense that defendants are equally exposed to adverse costs judgments, it is arguable that the "loser pays" aspect of Canadian patent litigation is not a strong deterrent to PAE litigation.    

Security for Costs

Related to the comments above regarding costs for a successful party is the concept of security for costs. Under Canada's legal system, if a plaintiff does not have sufficient assets within Canada to satisfy a potential costs judgment against it, the Court will require it to post security for the costs of the defendant, e.g., pay cash into Court pending final judgment in the litigation. Where there is a settlement or the plaintiff PAE is successful at trial, the security is paid back to the PAE with interest. Where the PAE is not successful, the security is paid to the defendant as compensation for its legal costs.

Requiring a plaintiff to post security for costs is a factor that may discourage PAEs from commencing a suit in Canada.  However, the requirement to post security is somewhat tempered by the fact that the security may be posted in instalments (with the initial instalments typically being less than the later instalments), and given that the total amount of security is typically less than the total amount recoverable by a defendant at the end of trial (which amount is already discounted from actual fees, as discussed above).

Permanent Injunctions

In the U.S., permanent injunctions for successful PAEs are virtually unheard of ever since the U.S. Supreme Court's decision in eBay Inc. et al. v. MercExchange, L.L.C., 547 U.S. 388 (2006) (eBay). In Canada, however, there is no equivalent to the eBay case. Rather, a permanent injunction will normally follow once the Court has found that a patent is valid and has been infringed. An injunction will be refused "only in very rare circumstances" according to Canadian case law. 

While there are no recent Canadian decisions addressing whether a PAE, as a matter of policy, should be entitled to or denied a permanent injunction, there is some guidance in the case law that suggests the Court will examine each dispute on a case-by-case basis. Considerations for the Court in this regard may include whether the infringing product may be substituted with a reasonable alternative, and whether, based on the particular interests of the parties and the public at large, damages alone may be sufficient compensation. For example, there may be an argument that damages alone are adequate where a PAE: uses the threat of an injunction for undue leverage, does not have a competing product or other particular interest in the market, is only interested in obtaining licensing revenues, and would enjoy a greater financial benefit with ongoing and/or future royalties.  However, such an argument would need to be balanced against the general practice of granting permanent injunctions, particularly where an infringing product may be substituted with a reasonable alternative.

Accordingly, the current state of the law in Canada may be favourable to PAEs in that they may, in certain situations, be able to obtain a permanent injunction. The availability of a permanent injunction as a remedy for a PAE can be a powerful point of leverage over an accused infringer. That said, the desire for this remedy needs to be balanced against the reality that a compulsory license – and not an injunction – could result in the greatest financial benefit to the PAE.

Monetary Remedies

In the U.S., actual or constructive notice of patent infringement must be provided to an accused infringer for damages to accrue.  Where notice is not provided, this can limit the scope of recoverable damages for a PAE. In Canada, no notice is required. An accused infringer may be found liable for at least a reasonable royalty from the date of publication of the application for a patent. With respect to post-grant infringement, an accused infringer may alternatively be found liable for an accounting of profits, i.e., the accused infringer's profits attributable to the infringement may be disgorged.

In addition, the U.S. allows for the recovery of treble damages for cases involving wilful infringement. Canada does not permit recovery of treble damages, though in limited cases punitive damages may be available.

Canada's flexible monetary remedies may favour PAEs considering Canada as a potential venue for enforcement in certain cases. However, Canada's smaller market size and the unavailability of treble damages may result in the total quantum of damages being less substantial as compared to the U.S.

Jury Trials and Forum Shopping

Outside of the niche of pharmaceutical litigation, Canadian patent lawsuits do not typically result in the large monetary awards seen in other jurisdictions, most notably the U.S. This can be explained by the fact that the U.S. is roughly ten times the size of Canada, and so often has ten times the market size for an accused product, but there may also be other factors at play.  For example, the multiple hundreds of millions of dollars in damages awards in the U.S. often come from U.S. patent trials that are decided by a jury. In Canada, first instance patent trials are only decided by a single judge, as the Federal Courts Act prohibits a trial by jury for any action before the Federal Court and the Federal Court of Appeal.  Furthermore, certain jurisdictions in the U.S. are well known for being patent-holder friendly, such as the Eastern District of Texas. In contrast, Canadian patent matters are almost always argued before the Federal Court of Canada because orders from the Federal Court are enforceable across the entire country and the judges of the Federal Court have the most experience adjudicating patent matters. Accordingly, a PAE that is considering activity in Canada would not have the benefit of a jury trial and forum shopping that they may be accustomed to in the U.S.

Validity Challenges

In the U.S., there are several procedures for challenging a patent's validity post-grant. The most popular procedure currently is the Inter Partes Review (IPR). Not only have accused infringers enjoyed good success with having patent claims invalidated in IPRs, but also many PAEs have seen their district court cases stayed pending the resolution of IPR proceedings.

In contrast, Canada has a re-examination procedure for the post-grant review of a patent's validity, but the process is patentee-friendly. In this regard, it is an ex parte process that allows a patentee to amend its claims without rebuttal from the accused infringer. Moreover, statistics show that a significant majority of outcomes from Canadian re-examinations favour the patentee.  Furthermore, even if a patentee is pulled into a re-examination proceeding, it likely will not result in a stay of any litigation. If anything, Canadian law provides that it would be the re-examination proceeding that would be stayed in favour of the litigation based on the preference to resolve validity issues in open court.

Thus, a PAE that is considering activity in Canada would not face the same post-grant patent office validity challenge landscape as they would in the U.S.

Take-Away Points Regarding Responses to PAEs

In our view, there are a number of differences between the Canadian legal system and the U.S. legal system that may act as a buffer against increased PAE activity here in Canada. Indeed, despite there being a number of differences between the two legal systems that actually favour a PAE litigating in Canada, we have not seen, to date, an explosion in the number of PAE cases filed in Canada, or even so much as a continuous upward trend in the number of PAE cases. While there is no specific rationale to suspect that PAEs will increase activity directed at specific industries in Canada, it is probably safe to assume that as a particular  market grows, so too does the interest of the PAEs. Furthermore, while the U.S. PAE experience tells us that PAEs have typically focused on enforcing high-tech and software patents, the incidence of PAEs engaging other industries in the U.S., such as the medical device industry, is on the rise.  

As your company grows, its success could attract the attention of PAEs. As a proactive step, you may now consider collecting and cataloguing publications that are particularly relevant to your technology. The older the publication, the greater the chance that it could be useful to attack the validity of a patent that is asserted against your company. 

While we do not expect there to be a sharp near term increase in PAE-initiated patent litigation in Canada, the potential for more litigation is there in view of the numerous factors making Canada at least somewhat of an attractive venue for PAEs, and the ever-expanding enforcement efforts of PAEs to jurisdictions outside the U.S. Therefore, it is useful to understand what steps you can take to contribute, both proactively and reactively, towards formulating a response to a cease and desist letter from a PAE. Actively contributing towards responding to the letter will engage you and your resources in the key issues at stake, and, at least in our experience, help keep the emotions at bay.  

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
8 Nov 2016, Seminar, Ottawa, Canada

The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.

22 Nov 2016, Seminar, Ottawa, Canada

From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.

7 Dec 2016, Seminar, Ottawa, Canada

Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.